Hazra M. A rational pharmacotherapeutic study of comparative safety among topical anti-acne 1% nadifloxacin monotherapy, 0.1% adapalene monotherapy, 0.025% tretinoin monotherapy, 1% nadifloxacin and 0.1% adapalene combination therapy and 1% nadifloxacin and 0.025% tretinoin combination therapy, in mild to moderate acne vulgaris, in tertiary care hospitals. Int J Basic Clin Pharmacol [Internet]. 2019 Aug. 28 [cited 2025 Oct. 21];8(9):1959-65. Available from: https://www.ijbcp.com/index.php/ijbcp/article/view/3627